Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
18 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hemoshear-therapeutics-to-participate-in-svb-leerink-securities-biopharma-private-company-connect-301650935.html
10 Aug 2022
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hemoshear-develops-new-human-tissue-based-model-of-rare-liver-disease-under-research-collaboration-with-takeda-301602822.html
16 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hemoshear-therapeutics-identifies-second-novel-target-to-treat-nash-through-successful-collaboration-with-takeda-301424799.html
21 Sep 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hemoshear-therapeutics-advancing-several-novel-compounds-for-horizon-therapeutics-plc-gout-discovery-pipeline-301380995.html
10 Feb 2021
// BIOSPACE
https://www.biospace.com/article/releases/hemoshear-therapeutics-raises-40-million-in-series-a-financing-to-advance-rare-disease-portfolio/
16 Dec 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hemoshear-therapeutics-hst5040-receives-us-orphan-drug-designations-for-treatment-of-methylmalonic-acidemia-and-propionic-acidemia-301193648.html
ABOUT THIS PAGE